Key points interpretation of Expert consensus on clinical diagnosis and treatment path of retinal vein occlusion in China
10.3760/cma.j.cn511434-20240320-00113
- VernacularTitle:《中国视网膜静脉阻塞临床诊疗路径专家共识》要点解读
- Author:
Xiaoxin LI
1
Author Information
1. 厦门大学附属厦门眼科中心, 厦门 361003
- Keywords:
Retinal vein occlusion;
Anterior segment neovascularization;
Neovascular glaucoma;
Macular edema;
Anti-vascular endothelial growth factor drug therapy;
Las
- From:
Chinese Journal of Ocular Fundus Diseases
2024;40(4):264-267
- CountryChina
- Language:Chinese
-
Abstract:
Retinal vein occlusion (RVO) is a closely related disease of ophthalmology and systemic diseases. The Expert consensus on clinical diagnosis and treatment path of retinal vein occlusion in China (consensus) emphasizes that etiological diagnosis and treatment should be paid primary attention to, and etiological exploration should be placed in an important position in the diagnosis and treatment path. In addition to etiological treatment, the consensus emphasizes that clinical attention should be paid to the management of anterior segment neovascularization, neovascular glaucoma and macular edema. Especially for patients with short course of central retinal vein occlusion, the occurrence of 100-day glaucoma should be vigilant, and active anti-vascular endothelial growth factor (VEGF) drugs, laser photocoagulation and intraocular pressure treatment should be taken. For the treatment of macular edema, the consensus points out that anti-VEGF drugs and intraocular glucocorticoid sustained-release agents are effective, but the latter should be used cautiously to avoid problems such as high intraocular pressure glaucoma and accelerated cataract formation. For deficient RVO, the consensus defines its concept, defines the time point of treatment when combined with macular edema, and clarifies the applicable conditions of laser therapy.
